Skip to main content
Premium Trial:

Request an Annual Quote

GeneData Licenses Software to Singapore Cancer Center

NEW YORK, July 8 - Genedata, of Basel, Switzerland, and Singapore's National Cancer Center said today they have begun a gene-expression analysis collaboration in the area of cancer research.


Under this agreement, the center has licensed Genedata's Expressionist microarray analysis software.


Researchers at the center will use the platform to identify sets of diagnostic marker genes that can be used to classify tissues by type and subtype of cancer; as well as to understand gene function and mechanisms of tumor progression, as well as oncogenic signal transduction pathways, the parties said. Genedata's scientists will work with the center researchers on developing the applications of Expressionist in this area.

The Scan

Omicron's Emergence

The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes.

Not as Much

Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says.

Bats That Hang Together

Discover magazine writes that researchers have found a social microbiome among vampire bats.

PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers

In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.